107 results
Page 4 of 6
DEFA14A
ui7yz
21 Jun 21
Additional proxy soliciting materials
9:25am
8-K
EX-99.2
4k61fl50
12 May 21
Diffusion Pharmaceuticals Reports First Quarter Financial Results
7:30am
8-K
EX-99.1
qahrc k94b
12 May 21
Diffusion Pharmaceuticals Reports First Quarter Financial Results
7:30am
8-K
EX-99.1
cs0rq2tv2 kxa
25 Mar 21
Diffusion Pharmaceuticals Completes Enrollment and Dosing in TCOM Study
5:20pm
8-K
EX-99.1
ol36os5l4t
18 Mar 21
Regulation FD Disclosure
4:14pm
8-K
EX-99.1
40c4jlkxhukihxv
17 Mar 21
Diffusion Pharmaceuticals Reports 2020 Financial Results and Provides Business Update
4:36pm
8-K
EX-99.3
vavlo9ghsb5dy bgv
18 Feb 21
Diffusion Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock
4:52pm
8-K
EX-99.4
v0smacxx
18 Feb 21
Diffusion Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock
4:52pm
8-K
EX-99.2
717mcdxu3 5f5
18 Feb 21
Diffusion Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock
4:52pm
8-K
EX-99.1
wmhlvh3120 2xx4qv2
18 Feb 21
Diffusion Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock
4:52pm
424B5
cg7su88321gmi4z3crl
17 Feb 21
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
ltcbdth3qqp5gugq6fcw
16 Feb 21
Diffusion Pharmaceuticals Completes Phase 1b Study of TSC in Hospitalized COVID-19 Patients
8:10am
8-K
EX-99.1
9fyce5g5yskjh
12 Feb 21
Note Regarding Forward-looking Statements
8:19am
FWP
u7k2gzf
11 Feb 21
Free writing prospectus
9:56pm
FWP
wazcga37
11 Feb 21
Free writing prospectus
5:29pm
424B5
bu0 dwlws
11 Feb 21
Prospectus supplement for primary offering
5:28pm
8-K
EX-99.1
nh0s0l1po quahw3qh5a
12 Nov 20
Diffusion Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Updates
4:57pm